| Taylor Robichaud, | |
|
71 Boxwood St, Williston, VT 05495-8211 | |
| (151) 826-8300 | |
| Not Available |
| Full Name | Taylor Robichaud |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 71 Boxwood St, Williston, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609349588 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 033.0112527 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Taylor Robichaud, 1300 Spear St, South Burlington, VT 05403-7403 Ph: (518) 268-3008 | Taylor Robichaud, 71 Boxwood St, Williston, VT 05495-8211 Ph: (151) 826-8300 |
News Archive
Schering-Plough Corporation today announced it has initiated sponsorship of two projects in India to reduce the incidence of human and animal rabies through improved educational awareness and mass vaccination of dogs. The company will donate $200,000 and rabies vaccine from Intervet/Schering-Plough as well as share expertise with partners to support successful implementation of the projects in ten villages surrounding Bangalore and Pune, India.
Alcohol use early in the pregnancy by the mother may be a risk factor for a condition in which an infant's intestines develop outside the abdomen, according to a study published in the Journal of Maternal-Fetal & Neonatal Medicine.
Medtronic CEO Bill Hawkins says the products made by his company, like pacemakers, insulin pumps and neurostimulators are the "ultimate personal technologies," according to CNNMoney. He said a shift in his industry is moving towards health information technology that people will depend on and use with their cell phones and laptops.
Dendreon Corporation today announced that the U.S. Food and Drug Administration (FDA) provided written acknowledgement that the Company's amended Biologics License Application (BLA) for PROVENGE® (sipuleucel-T) is a complete response. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) date of May 1, 2010, by which time it will respond to Dendreon's amended BLA. Dendreon is seeking licensure for PROVENGE for men with metastatic castrate-resistant prostate cancer (CRPC).
› Verified 6 days ago
Sean Billings Remillard, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 Blair Park Rd, Williston, VT 05495 Phone: 800-861-1903 | |
Alexandra M Jones, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 108 Cornerstone Dr, Rite Aid, Williston, VT 05495 Phone: 802-878-1118 | |
Needa Ahmed, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 49 Wright Ave, Williston, VT 05495 Phone: 802-872-8840 | |
Jason To, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 49 Wright Ave, Williston, VT 05495 Phone: 802-872-8840 | |
Garret H Huyer, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 108 Cornerstone Dr, Williston, VT 05495 Phone: 802-878-1118 | |
Matthew Witt Hinton, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 Blair Park Rd, Williston, VT 05495 Phone: 802-878-9116 | |
Dr. Cheryl Tuiqere, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 Blair Park Rd Ste 195, Healthdirect Pharmacy / Kinney Drugs #69, Williston, VT 05495 Phone: 800-861-1903 Fax: 800-861-1904 |